XML 19 R2.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 168,318 $ 145,054
Marketable securities 155,564 152,167
Total cash, cash equivalents, and marketable securities 323,882 297,221
Accounts receivable 201,585 255,150
Unbilled receivables 196,279 213,719
Other current assets 73,982 80,388
Total current assets 795,728 846,478
Unbilled receivables 79,704 95,806
Goodwill 81,434 81,399
Other long-term assets 324,975 333,989
Total assets 1,281,841 1,357,672
Current liabilities:    
Accounts payable 12,565 18,195
Accrued expenses 45,432 50,355
Accrued compensation and related expenses 56,574 127,728
Deferred revenue 342,591 325,212
Other current liabilities 17,802 17,450
Total current liabilities 474,964 538,940
Convertible senior notes, net 561,655 593,609
Operating lease liabilities 76,082 79,152
Other long-term liabilities 14,644 15,128
Total liabilities 1,127,345 1,226,829
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 82,940 and 82,436 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 829 824
Additional paid-in capital 272,481 229,602
Accumulated deficit (97,287) (76,513)
Accumulated other comprehensive (loss) (21,527) (23,070)
Total stockholders’ equity 154,496 130,843
Total liabilities and stockholders’ equity $ 1,281,841 $ 1,357,672